Company: AEMD
Filing Date: 2025-07-25
Form Type: DRS
Source: 0001683168-25-005397
Chunk: 80

Company: AETHLON MEDICAL INC
Filing Date: 2025-07-25
Form: DRS
Chunk 80
---
 misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the
time limit prescribed by the securities legislation of the purchaser’s province or territory. The purchaser should refer to any
applicable provisions of the securities legislation of the purchaser’s province or territory for particulars of these rights or
consult with a legal advisor.

Pursuant to section 3A.3 (or,
in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section 3A.4) of National Instrument
33-105 Underwriting Conflicts (NI 33-105), the placement agent is not required to comply with the disclosure requirements
of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.

Notice to Prospective Investors in Israel

The securities offered by
this prospectus have not been approved or disapproved by the Israeli Securities Authority (the ISA), or ISA, nor have such securities
been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public in Israel, absent the
publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection with this offering or publishing the
prospectus; nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered an opinion
as to the quality of the securities being offered. Any resale in Israel, directly or indirectly, to the public of the securities offered
by this prospectus is subject to restrictions on transferability and must be effected only in compliance with the Israeli securities laws
and regulations.

<div align='center'>LEGAL MATTERS</div>

The validity of the securities
being offered by this prospectus supplement will be passed upon for us Procopio Cory Hargreaves & Savitch, LLP, San Diego, California.
Certain legal matters in connection with this offering will be passed upon for the placement agent by Pryor Cashman LLP, New York, New
York.

<div align='center'>EXPERTS</div>

The consolidated financial
statements of Aethlon Medical, Inc. for the year ended March 31, 2025 incorporated by reference in this Registration Statement and
Prospectus have been so incorporated in reliance on the report of Haskell & White, LLP, an independent registered public accounting
firm, given on the authority of said firm as experts in auditing and accounting.

| 43 |

The consolidated financial
statements of Aethlon Medical, Inc. for the year